Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Aug 27, 2021
Open Peer Review Period: Aug 27, 2021 - Sep 10, 2021
Date Accepted: Dec 28, 2021
Date Submitted to PubMed: Dec 29, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study

Li Y, Xu J, Gu Y, Sun X, Dong H, Chen C

The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study

JMIR Public Health Surveill 2022;8(3):e33191

DOI: 10.2196/33191

PMID: 34963658

PMCID: 8928052

The Disease and Economic Burdens of Oesophageal Cancer in China from 2013 to 2030: A Dynamic Cohort Modelling Study

  • Yuanyuan Li; 
  • Junfang Xu; 
  • Yuxuan Gu; 
  • Xueshan Sun; 
  • Hengjin Dong; 
  • Changgui Chen

ABSTRACT

Background:

Esophageal cancer (EC) is the sixth leading cause of tumor death worldwide. Estimates of the EC burden in China are necessary that could offer evidence-based suggestions for local cancer control.

Objective:

Our paper aimed to predict the disease burden of EC in China through the estimation of the disability-adjusted life years (DALY) and DMC by gender for the period of 2013 to 2030.

Methods:

A dynamic cohort Markov model was developed to simulate the EC prevalence, disability-adjusted life years (DALY), and direct medical expenditure (DME) based on gender. JoinPoint Regression Program was used to calculate the average annual percentage change (AAPC) of DALY rates, while the average annual growth rate (AAGR) was applied to analyze the changing trend of DME over time.

Results:

From 2013 to 2030, the predicted EC prevalence increased from 60.98 to 64.51 per 100 000, with the annual EC cases increased from 835.57 thousand to 931.79 thousand. The DALYs increased from 3003.38 to 3644.35 thousand, and the YLL accounted for the majority of DALYs. The DALY rates per 100 000 people increased in males (302.89 – 384.31 per 100 000), and it decreased in females (131.21- 115.91 per 100 000). The AAPC were 0.8% (95% CI, 0.8%- 0.9%), 1.4%(95% CI, 1.3%- 1.5%), and -0.7%(95% CI, -0.8%- -0.7%) for both-sex, males and females, respectively. The DME increased from 33.378 to 76.391 billion, and the AAGR was 5.0%. DME was 2-3 fold higher for males than for females.

Conclusions:

EC still caused a severe burden on society. YLL was responsible for the majority of the DALYs, which addressed an urgent need to establish a beneficial policy to reduce the EC burden.


 Citation

Please cite as:

Li Y, Xu J, Gu Y, Sun X, Dong H, Chen C

The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study

JMIR Public Health Surveill 2022;8(3):e33191

DOI: 10.2196/33191

PMID: 34963658

PMCID: 8928052

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.